{"count": 2, "results": [{"_id": "20810669", "pmid": 20810669, "title": "Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.", "journal": "Cancer Prev Res (Phila)", "authors": ["Hosono K", "Endo H", "Takahashi H", "Sugiyama M", "Sakai E", "Uchiyama T", "Suzuki K", "Iida H", "Sakamoto Y", "Yoneda K", "Koide T", "Tokoro C", "Abe Y", "Inamori M", "Nakagama H", "Nakajima A"], "date": "2010-09-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-10-0186", "meta_date_publication": "2010 Sep", "meta_volume": "3", "meta_issue": "9", "meta_pages": "1077-83", "score": 50077.3, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ suppresses @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal aberrant@@@ crypt @<m>DISEASE_Epilepsy_Partial_with_Variable_Foci</m> @DISEASE_MESH:C565785 @@@foci@@@ in a short-term clinical trial.", "citations": {"NLM": "Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, Suzuki K, Iida H, Sakamoto Y, Yoneda K, Koide T, Tokoro C, Abe Y, Inamori M, Nakagama H, Nakajima A. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila). 2010 Sep;3(9):1077-83. PMID: 20810669", "BibTeX": "@article{20810669, title={Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.}, author={Hosono K and Endo H and Takahashi H and Sugiyama M and Sakai E and Uchiyama T and Suzuki K and Iida H and Sakamoto Y and Yoneda K and Koide T and Tokoro C and Abe Y and Inamori M and Nakagama H and Nakajima A}, journal={Cancer Prev Res (Phila)}, volume={3}, number={9}, pages={1077-83}}"}}, {"_id": "21631893", "pmid": 21631893, "title": "Metformin as an antitumor agent in cancer prevention and treatment.", "journal": "J Diabetes", "authors": ["Li D"], "date": "2011-12-01T00:00:00Z", "doi": "10.1111/j.1753-0407.2011.00119.x", "meta_date_publication": "2011 Dec", "meta_volume": "3", "meta_issue": "4", "meta_pages": "320-7", "score": 50059.047, "text_hl": "In addition, a recent clinical trial has shown that short-term use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces aberrant crypt @<m>DISEASE_Epilepsy_Partial_with_Variable_Foci</m> @DISEASE_MESH:C565785 @@@foci@@@ (@DISEASE_Aberrant_Crypt_Foci @DISEASE_MESH:D058739 @@@ACF@@@) formation in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Aberrant_Crypt_Foci @DISEASE_MESH:D058739 @@@ACF@@@. ", "citations": {"NLM": "Li D. Metformin as an antitumor agent in cancer prevention and treatment. J Diabetes. 2011 Dec;3(4):320-7. PMID: 21631893", "BibTeX": "@article{21631893, title={Metformin as an antitumor agent in cancer prevention and treatment.}, author={Li D}, journal={J Diabetes}, volume={3}, number={4}, pages={320-7}}"}}]}